Bhim S. Singhal
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
Journal: Journal of neurology
Published: November 01, 2025
Predicting disease progression in multiple sclerosis with clinically accessible information and technology.
Journal: Journal of neurology
Published: September 16, 2025
Signature Clinical Signs in Neurology.
Journal: Annals of Indian Academy of Neurology
Published: July 14, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Journal: NPJ digital medicine
Published: February 13, 2025
Explainable time-to-progression predictions in multiple sclerosis.
Journal: Computer methods and programs in biomedicine
Published: July 16, 2024
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
Journal: Journal of neurology
Published: April 18, 2023
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Journal: Brain : a journal of neurology
Published: March 01, 2023
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 28, 2023
Seronegative Autoimmune Limbic Encephalitis: A Case Report.
Journal: The Journal of the Association of Physicians of India
Published: September 09, 2022
A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: June 18, 2022
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Journal: European journal of neurology
Published: February 17, 2022
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension: A Case Report.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 05, 2021
Last Updated: 09/26/2026